Qu, Yang <br/><br/>
Inhibition of inflammation mediates the protective effect of atorvastatin reload in patients with coronary artery disease undergoing noncardiac emergency surgery.  [electronic resource] 

 -  Coronary artery disease  Dec 2014 
 - 678-84 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1473-5830 
<br/><br/><label>Standard No.: </label>10.1097/MCA.0000000000000143  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Disease<br/>Aged<br/>Anti-Inflammatory Agents--administration & dosage<br/>Atorvastatin--administration & dosage<br/>Biomarkers--blood<br/>C-Reactive Protein--metabolism<br/>Chi-Square Distribution<br/>China--epidemiology<br/>Coronary Artery Disease--complications<br/>Disease-Free Survival<br/>Drug Administration Schedule<br/>Emergencies<br/>Female<br/>Heart Failure--diagnosis<br/>Hospitalization<br/>Humans<br/>Incidence<br/>Inflammation Mediators--blood<br/>Interleukin-6--blood<br/>Kaplan-Meier Estimate<br/>Logistic Models<br/>Male<br/>Middle Aged<br/>Multivariate Analysis<br/>Odds Ratio<br/>Prospective Studies<br/>Risk Factors<br/>Single-Blind Method<br/>Surgical Procedures, Operative--adverse effects<br/>Time Factors<br/>Treatment Outcome